Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Product Approvals
|
Clinical Trials
|
Product Filings
|
Product Safety
|
Preclinical
|
Product Delays
|
Research & Development - Product Safety
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
US opioid manufacturers propose phase-in of class-wide REMS
07 December 2009
Zydus sets sight on US controlled substances market via Nesh...
US regulators unveil plan to transform FDA to global agency...
US FDA's "Safe Use" programme aims to reduce medication errors and misuse
09 November 2009
Botox REMS spurs Allergan's challenge to US off-label promotion rules
05 October 2009
US FDA orders "black box" suicidality warnings and studies for Chantix and Zyban
02 July 2009
More resources needed for EU and US regulatory demands, report reveals
29 June 2009
>> More News...
LATEST ANALYSIS
Market Insight – Managing fraud risks
08 August 2008
Market Insight - Behind-the-counter: marketing challenges for a potential new drug class
08 August 2008
Market Insight: F-D-triple-A steps out to a mixed reception
31 July 2008
>> More Analysis...
REFINE BY
COMPANY/ORGANISATION
PFIZER
NOVARTIS
GLAXOSMITHKLINE
SANOFI-AVENTIS
CONDITION
CANCER
PAIN
DIABETES
ARTHRITIS
GEOGRAPHY
JAPAN
GERMANY
INDIA
CANADA
DRUG
BEVACIZUMAB
SIMVASTATIN
AMLODIPINE
INFLIXIMAB